TODAY'S HEADLINES
Bernard Lisitza has been rewarded more than $31 million for whistleblower information provided in cases against Walgreens, CVS, Omnicare, and Johnson & Johnson, according to a report in the Chicago Tribune. » More
|
|
A former Ranbaxy executive told CBS News that the company often skipped the required steps for approval of its generic drugs, and in some cases presented fake data to get its products in U.S. pharmacies. » More
|
ADVERTISEMENT
New Zephrex-D® a Safe choice for unsurpassed congestion relief
New Zephrex-D ® is the only cold and sinus medication that provides the unsurpassed decongestant performance of pseudoephedrine in a unique formula that significantly disrupts meth making
 www.zephrex-d.com
|
|
The National Association of Chain Drug Stores and the National Community Pharmacists Association have endorsed legislation that would restore the ability of consumers to purchase OTC medications using pre-tax dollars from flexible spending accounts and health savings accounts without obtaining a doctor's endorsement. » More
|
|
Aaron Jennissen, VP, Pharmacy Operations, Thrifty White Pharmacy, discusses how that chain is using telepharmacy to improve both customer loyalty and reach. » More
|
Continuing Education
This month, Drug Topics offers the first of a two-part CPE series, "MTM considerations in multiple sclerosis." Earn up to 2 credits by completing this knowledge-based activity. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
|
|
|
Like
Tweet
